Skip to content
Trial Eligibility
Menu

Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia

NCT00001406

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This study will investigate how, why and under what conditions eosinophils (a type of white blood cell) become activated and will examine their function in immune reactions. Eosinophil counts often rise in response to allergies, asthma, and parasitic worm infections. They can also go up in uncommon autoimmune conditions and, rarely, in association with tumors. Elevated levels of these cells is called eosinophilia.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Immune System Diseases
  • Eosinophilia
  • Helminthiasis
  • Hypersensitivity
  • Parasitic Disease

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
1 year to 100 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Last updated on ClinicalTrials.gov
September 28, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Maryland · 1

  • National Institutes of Health Clinical Center · Bethesda, MD

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.